This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. NOTV, AIKI, LUNA, ONMD, BIAF, ISPC, DKDCA, IQV, INCY, and ICLRShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), AIkido Pharma (AIKI), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), Incyte (INCY), and ICON Public (ICLR). Bioanalytical Systems vs. Its Competitors Inotiv AIkido Pharma Luna Innovations OneMedNet bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA Incyte ICON Public Bioanalytical Systems (NASDAQ:BASI) and Inotiv (NASDAQ:NOTV) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, risk, valuation, dividends, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has more volatility & risk, BASI or NOTV? Bioanalytical Systems has a beta of 1.92, meaning that its share price is 92% more volatile than the S&P 500. Comparatively, Inotiv has a beta of 4.08, meaning that its share price is 308% more volatile than the S&P 500. Which has higher earnings and valuation, BASI or NOTV? Bioanalytical Systems has higher earnings, but lower revenue than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioanalytical Systems$60.47M0.47-$4.68M-$0.35-7.26Inotiv$480.40M0.17-$108.44M-$3.19-0.74 Is BASI or NOTV more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Bioanalytical Systems-7.75% -42.74% -6.38% Inotiv -25.40%-15.41%-3.58% Do institutionals & insiders have more ownership in BASI or NOTV? 10.6% of Bioanalytical Systems shares are owned by institutional investors. Comparatively, 18.2% of Inotiv shares are owned by institutional investors. 11.5% of Bioanalytical Systems shares are owned by company insiders. Comparatively, 7.8% of Inotiv shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer BASI or NOTV? Bioanalytical Systems received 108 more outperform votes than Inotiv when rated by MarketBeat users. However, 50.00% of users gave Inotiv an outperform vote while only 35.85% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformBioanalytical SystemsOutperform Votes12835.85% Underperform Votes22964.15% InotivOutperform Votes2050.00% Underperform Votes2050.00% Do analysts prefer BASI or NOTV? Inotiv has a consensus price target of $5.00, suggesting a potential upside of 112.77%. Given Inotiv's stronger consensus rating and higher possible upside, analysts plainly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Inotiv 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer BASI or NOTV? In the previous week, Inotiv had 2 more articles in the media than Bioanalytical Systems. MarketBeat recorded 2 mentions for Inotiv and 0 mentions for Bioanalytical Systems. Inotiv's average media sentiment score of 1.09 beat Bioanalytical Systems' score of 0.00 indicating that Inotiv is being referred to more favorably in the news media. Company Overall Sentiment Bioanalytical Systems Neutral Inotiv Positive SummaryInotiv beats Bioanalytical Systems on 12 of the 18 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$28.27M$3.36B$5.61B$8.62BDividend YieldN/A2.05%5.28%4.17%P/E Ratio-6.05122.3027.1419.96Price / Sales0.47166.21411.83157.63Price / Cash558.4034.5738.2534.64Price / Book3.682.577.064.69Net Income-$4.68M$118.81M$3.23B$248.14M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$2.54-10.6%N/A+56.0%$28.27M$60.47M-6.05397Gap UpHigh Trading VolumeNOTVInotiv2.2358 of 5 stars$2.68-1.1%$5.00+86.6%+42.7%$92.07M$480.40M-0.582,100Short Interest ↑AIKIAIkido PharmaN/A$4.42-3.7%N/A+160.0%$24.24M$10K-1.144High Trading VolumeLUNALuna Innovations0.476 of 5 stars$0.65-7.1%N/A-79.9%$22.07M$116.61M0.00390News CoverageONMDOneMedNet0.8053 of 5 stars$0.39+3.3%N/A-72.0%$12.01M$532K-1.192Positive NewsGap UpBIAFbioAffinity Technologies1.7674 of 5 stars$0.28+7.7%$6.00+2,020.1%-86.7%$7.91M$8.81M-0.3510News CoverageShort Interest ↑Gap UpISPCiSpecimen0.5763 of 5 stars$1.20+3.4%N/A+226.3%$3.00M$8.06M-0.0660Short Interest ↑Gap UpDKDCAData Knights AcquisitionN/A$0.40-4.1%N/A-68.2%$2.07MN/A-2.112Gap UpHigh Trading VolumeIQVIQVIA4.8704 of 5 stars$139.14+0.0%$226.32+62.7%-26.3%$24.07B$15.50B18.5586,000Short Interest ↑INCYIncyte4.5525 of 5 stars$65.43+0.2%$73.60+12.5%+15.8%$12.67B$4.41B242.342,320Positive NewsICLRICON Public4.6185 of 5 stars$129.30+0.3%$213.08+64.8%-54.1%$10.44B$8.19B13.5741,100 Related Companies and Tools Related Companies Inotiv Competitors AIkido Pharma Competitors Luna Innovations Competitors OneMedNet Competitors bioAffinity Technologies Competitors iSpecimen Competitors Data Knights Acquisition Competitors IQVIA Competitors Incyte Competitors ICON Public Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BASI Stock Free BASI Stock Alerts